Physician profile
Lisa E Mcmahon
NPI 1942270327
$87,267.45
in general payments reported to CMS, 2019-2025
11 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $45.89 · 2021: $214 · 2022: $246 · 2023: $25K · 2024: $22K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $71K · Travel and Lodging: $13K · Food and Beverage: $2,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $70,851.50 |
| Travel and Lodging | $12,859.96 |
| Food and Beverage | $2,705.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $62,244.71 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| L&K Biomed Co. , Ltd. | $19,854.95 | 2025 | Castleloc Pectus System |
| Zimmer Biomet Holdings, INC. | $3,044.38 | 2019-2024 | Medline |
| Abbvie INC. | $1,063.38 | 2019-2025 | |
| Stryker Corporation | $423.03 | 2024 | 1788 |
| Kls-Martin L.P. | $294.83 | 2023-2025 | |
| Teleflex LLC | $110.21 | 2022 | |
| Medtronic, INC. | $103.27 | 2022-2025 | Ligasure, Signia |
| Tela Bio, INC. | $64.88 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Avanos Medical | $45.89 | 2020 | |
| Boston Scientific Corporation | $17.92 | 2025 | Emblem Mri S-Icd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Mcmahon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.